News: Regeneus presents at the ASX Spotlight Seri, page-8

re: News: Regeneus presents at the ASX Spotli... I feel the same Massey,Regeneus are at the forefront of the adipose cell technology.
Cell therapy will eventually hit like a tidal wave IMO as the word spreads about its success.
Regeneus is generating profits with Hi Q,cryoshot ,Alogen A brands.
They have their fingers in in many more trials.
Cryoshot trials on humans coming.The trials on dog cancerous tumours in the USA results so far being outstanding.
It is a high risk industry ,but i feel Regeneus are a much lower risk,than most.